GE Researchers Will Use $900K NHGRI Grant to Develop Single-Molecule Next-Gen Sequencer

GE, which has been selling Amersham Biosciences' MegaBace sequencers since it acquired Amersham in early 2004, has until now remained quiet about whether it is pursuing next-generation sequencing.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.